EUDA Health Holdings Limited (NASDAQ:EUDA - Get Free Report) was the recipient of a large increase in short interest in February. As of February 28th, there was short interest totalling 11,000 shares, an increase of 44.7% from the February 13th total of 7,600 shares. Based on an average daily trading volume, of 105,000 shares, the short-interest ratio is currently 0.1 days. Approximately 0.1% of the company's stock are sold short.
Hedge Funds Weigh In On EUDA Health
An institutional investor recently bought a new position in EUDA Health stock. XTX Topco Ltd purchased a new position in EUDA Health Holdings Limited (NASDAQ:EUDA - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 16,463 shares of the company's stock, valued at approximately $75,000. XTX Topco Ltd owned approximately 0.07% of EUDA Health at the end of the most recent reporting period. 4.35% of the stock is owned by institutional investors.
Analysts Set New Price Targets
Separately, Greenridge Global upgraded shares of EUDA Health to a "strong-buy" rating in a report on Monday, December 23rd.
Check Out Our Latest Stock Analysis on EUDA Health
EUDA Health Stock Performance
EUDA Health stock traded up $0.15 during mid-day trading on Thursday, reaching $4.16. The stock had a trading volume of 103,530 shares, compared to its average volume of 70,337. The company has a 50-day moving average price of $3.87 and a two-hundred day moving average price of $4.13. EUDA Health has a one year low of $1.61 and a one year high of $6.30.
EUDA Health Company Profile
(
Get Free Report)
EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses.
Featured Stories
Before you consider EUDA Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EUDA Health wasn't on the list.
While EUDA Health currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.